Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder.

Mello MF, Yeh MS, Barbosa Neto J, Braga LL, Fiks JP, Mendes DD, Moriyama TS, Valente NL, Costa MC, Mattos P, Bressan RA, Andreoli SB, Mari JJ.

BMC Psychiatry. 2009 May 29;9:28. doi: 10.1186/1471-244X-9-28.

2.

A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD.

Yeh MS, Mari JJ, Costa MC, Andreoli SB, Bressan RA, Mello MF.

CNS Neurosci Ther. 2011 Oct;17(5):305-10. doi: 10.1111/j.1755-5949.2010.00188.x. Epub 2010 Sep 23.

PMID:
21554564
3.
4.

Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study.

Tucker P, Trautman RP, Wyatt DB, Thompson J, Wu SC, Capece JA, Rosenthal NR.

J Clin Psychiatry. 2007 Feb;68(2):201-6.

PMID:
17335317
5.

Treatment of civilian and combat-related posttraumatic stress disorder with topiramate.

Andrus MR, Gilbert E.

Ann Pharmacother. 2010 Nov;44(11):1810-6. doi: 10.1345/aph.1P163. Epub 2010 Oct 5. Review.

PMID:
20923947
6.
8.

Nefazodone treatment for chronic posttraumatic stress disorder: an open trial.

Davis LL, Nugent AL, Murray J, Kramer GL, Petty F.

J Clin Psychopharmacol. 2000 Apr;20(2):159-64.

PMID:
10770453
9.

Fluoxetine versus placebo in posttraumatic stress disorder.

Martenyi F, Brown EB, Zhang H, Prakash A, Koke SC.

J Clin Psychiatry. 2002 Mar;63(3):199-206.

PMID:
11926718
10.

Topiramate in combat-related posttraumatic stress disorder.

Alderman CP, McCarthy LC, Condon JT, Marwood AC, Fuller JR.

Ann Pharmacother. 2009 Apr;43(4):635-41. doi: 10.1345/aph.1L578. Epub 2009 Mar 31.

PMID:
19336652
11.

Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.

Robert S, Hamner MB, Ulmer HG, Lorberbaum JP, Durkalski VL.

J Clin Psychiatry. 2006 Oct;67(10):1522-6.

PMID:
17107242
12.

A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder.

Panahi Y, Moghaddam BR, Sahebkar A, Nazari MA, Beiraghdar F, Karami G, Saadat AR.

Psychol Med. 2011 Oct;41(10):2159-66. doi: 10.1017/S0033291711000201. Epub 2011 Feb 24.

PMID:
21349225
13.

Baclofen treatment for chronic posttraumatic stress disorder.

Drake RG, Davis LL, Cates ME, Jewell ME, Ambrose SM, Lowe JS.

Ann Pharmacother. 2003 Sep;37(9):1177-81.

PMID:
12921495
14.

A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study.

Davis LL, Jewell ME, Ambrose S, Farley J, English B, Bartolucci A, Petty F.

J Clin Psychopharmacol. 2004 Jun;24(3):291-7.

PMID:
15118483
15.

Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder.

Berlin HA, Koran LM, Jenike MA, Shapira NA, Chaplin W, Pallanti S, Hollander E.

J Clin Psychiatry. 2011 May;72(5):716-21. doi: 10.4088/JCP.09m05266gre. Epub 2010 Aug 10.

PMID:
20816027
16.

SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.

Asnis GM, Kohn SR, Henderson M, Brown NL.

Drugs. 2004;64(4):383-404. Review.

PMID:
14969574
17.

Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial.

Villarreal G, Calais LA, CaƱive JM, Lundy SL, Pickard J, Toney G.

Psychopharmacol Bull. 2007;40(2):6-18.

PMID:
17514183
18.

Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder.

Zohar J, Amital D, Miodownik C, Kotler M, Bleich A, Lane RM, Austin C.

J Clin Psychopharmacol. 2002 Apr;22(2):190-5.

PMID:
11910265
19.

Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial.

Dunlop BW, Rothbaum BO, Binder EB, Duncan E, Harvey PD, Jovanovic T, Kelley ME, Kinkead B, Kutner M, Iosifescu DV, Mathew SJ, Neylan TC, Kilts CD, Nemeroff CB, Mayberg HS.

Trials. 2014 Jun 21;15:240. doi: 10.1186/1745-6215-15-240.

20.

An open-label study of mirtazapine as treatment for combat-related PTSD.

Alderman CP, Condon JT, Gilbert AL.

Ann Pharmacother. 2009 Jul;43(7):1220-6. doi: 10.1345/aph.1M009. Epub 2009 Jul 7.

PMID:
19584388
Items per page

Supplemental Content

Write to the Help Desk